English

The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 forms  
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000375.v2.p1
Description

pht000375.v2.p1

DUMMY ID NUMBER
Description

ID2

Data type

string

STUDY VISIT NUMBER (ALL PARTICIPANTS)
Description

VISNO

Data type

text

DRUSENOID PED FIELD 2 RT EYE (ALL PARTICIPANTS)
Description

REDRUSF2

Data type

text

NON-DRUSENOID PED FIELD 2 RT EYE (ALL PARTICIPANTS)
Description

RENDRUF2

Data type

text

SSR/HEMORRHAGIC RD FIELD 2 RT EYE (ALL PARTICIPANTS)
Description

RESSRF2

Data type

text

HARD EXUDATE FIELD 2 RT EYE (ALL PARTICIPANTS)
Description

REHDEXF2

Data type

text

SUBRETINAL/SUBRPE HEMORRHAGE FIELD 2 RT EYE (ALL PARTICIPANTS)
Description

RESUBHF2

Data type

text

SUBRETINAL FIBROSIS FIELD 2 RT EYE (ALL PARTICIPANTS)
Description

RESUBFF2

Data type

text

PC/AMD FIELD 2 RT EYE (ALL PARTICIPANTS)
Description

REPHCOF2

Data type

text

GEOGRAPHIC ATROPHY CENTER POINT RT EYE (ALL PARTICIPANTS)
Description

REGEOACT

Data type

text

GEOGRAPHIC ATROPHY AREA C/SUB RT EYE (ALL PARTICIPANTS)
Description

REGEOACS

Data type

text

GEOGRAPHIC ATROPHY W/I GRID RT EYE (ALL PARTICIPANTS)
Description

REGEOAWI

Data type

text

RPE DEPIGMENTATION AREA C/SUB+INNERS RT EYE (ALL PARTICIPANTS)
Description

RERPEDCI

Data type

text

RPE DEPIGMENTATION AREA W/I GRID RT EYE (ALL PARTICIPANTS)
Description

RERPEDWI

Data type

text

INCREASED PIGMENT AREA C/SUB+INNERS RT EYE (ALL PARTICIPANTS)
Description

REINCPCI

Data type

text

INCREASED PIGMENT AREA W/I GRID RT EYE (ALL PARTICIPANTS)
Description

REINCPWI

Data type

text

MAXIMUM DRUSEN SIZE W/I GRID RT EYE (ALL PARTICIPANTS)
Description

REDRSZWI

Data type

text

SOFT DRUSEN RT EYE (ALL PARTICIPANTS)
Description

REDRSOFT

Data type

text

DRUSEN AREA W/I GRID (ALL PARTICIPANTS)
Description

REDRARWI

Data type

text

RETICULAR DRUSEN RT EYE (ALL PARTICIPANTS)
Description

REDRRETI

Data type

text

CALCIFIED DRUSEN W/I OR OUTSIDE GRID RT EYE (ALL PARTICIPANTS)
Description

REDRCALC

Data type

text

DRUSEN CATEGORY RT EYE (ALL PARTICIPANTS)
Description

REELICAT

Data type

text

DRUSENOID PED FIELD 2 LT EYE (ALL PARTICIPANTS)
Description

LEDRUSF2

Data type

text

NON-DRUSENOID PED FIELD 2 LT EYE (ALL PARTICIPANTS)
Description

LENDRUF2

Data type

text

SSR/HEMORRHAGIC RD FIELD 2 LT EYE (ALL PARTICIPANTS)
Description

LESSRF2

Data type

text

HARD EXUDATE FIELD 2 LT EYE (ALL PARTICIPANTS)
Description

LEHDEXF2

Data type

text

SUBRETINAL/SUBRPE HEMORRHAGE FIELD 2 LT EYE (ALL PARTICIPANTS)
Description

LESUBHF2

Data type

text

SUBRETINAL FIBROSIS FIELD 2 LT EYE (ALL PARTICIPANTS)
Description

LESUBFF2

Data type

text

PC/AMD FIELD 2 LT EYE (ALL PARTICIPANTS)
Description

LEPHCOF2

Data type

text

GEOGRAPHIC ATROPHY CENTER POINT LT EYE (ALL PARTICIPANTS)
Description

LEGEOACT

Data type

text

GEOGRAPHIC ATROPHY AREA C/SUB LT EYE (ALL PARTICIPANTS)
Description

LEGEOACS

Data type

text

GEOGRAPHIC ATROPHY W/I GRID LT EYE (ALL PARTICIPANTS)
Description

LEGEOAWI

Data type

text

RPE DEPIGMENTATION AREA C/SUB+INNERS LT EYE (ALL PARTICIPANTS)
Description

LERPEDCI

Data type

text

RPE DEPIGMENTATION AREA W/I GRID LT EYE (ALL PARTICIPANTS)
Description

LERPEDWI

Data type

text

INCREASED PIGMENT AREA C/SUB+INNERS LT EYE (ALL PARTICIPANTS)
Description

LEINCPCI

Data type

text

INCREASED PIGMENT AREA W/I GRID LT EYE (ALL PARTICIPANTS)
Description

LEINCPWI

Data type

text

MAXIMUM DRUSEN SIZE W/I GRID LT EYE (ALL PARTICIPANTS)
Description

LEDRSZWI

Data type

text

SOFT DRUSEN LT EYE (ALL PARTICIPANTS)
Description

LEDRSOFT

Data type

text

DRUSEN AREA W/I GRID LT EYE (ALL PARTICIPANTS)
Description

LEDRARWI

Data type

text

RETICULAR DRUSEN LT EYE (ALL PARTICIPANTS)
Description

LEDRRETI

Data type

text

CALCIFIED DRUSEN W/I OR OUTSIDE GRID LT EYE (ALL PARTICIPANTS)
Description

LEDRCALC

Data type

text

DRUSEN CATEGORY LT EYE (ALL PARTICIPANTS)
Description

LEELICAT

Data type

text

PARTICIPANT DRUSEN CATEGORY (WORSE EYE; ALL PARTICIPANTS)
Description

DRUCAT

Data type

text

AMD SEVERITY SCALE SCORE LT EYE (ALL PARTICIPANTS)
Description

AMDSEVLE

Data type

text

AMD SEVERITY SCALE SCORE RT EYE (ALL PARTICIPANTS)
Description

AMDSEVRE

Data type

text

AMD SIMPLE SCALE SCORE (PERSON; ALL PARTICIPANTS)
Description

SCALE

Data type

text

LAST PHOTO IN CLINICAL TRIAL (ALL PARTICIPANTS)
Description

LASTCLINF

Data type

text

YEARS FROM RANDOMIZATION TO DATE OF FUNDUS PHOTO RT EYE (ALL PARTICIPANTS)
Description

REPHTIME

Data type

float

YEARS FROM RANDOMIZATION TO DATE OF FUNDUS PHOTO LT EYE (ALL PARTICIPANTS)
Description

LEPHTIME

Data type

float

Back to the top of the page

Similar models

The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 forms
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
pht000375.v2.p1
ID2
Item
DUMMY ID NUMBER
string
Item
STUDY VISIT NUMBER (ALL PARTICIPANTS)
text
VISNO
Code List
STUDY VISIT NUMBER (ALL PARTICIPANTS)
CL Item
Baseline visit (00)
CL Item
0.5-year (01)
CL Item
1-year (02)
CL Item
1.5-years (03)
CL Item
2-years (04)
CL Item
2.5-years (05)
CL Item
3-years (06)
CL Item
3.5-years (07)
CL Item
4-years (08)
CL Item
4.5-years (09)
CL Item
5-years (10)
CL Item
5.5-years (11)
CL Item
6-years (12)
CL Item
6.5-years (13)
CL Item
7-years (14)
CL Item
7.5-years (15)
CL Item
8-years (16)
CL Item
8.5-years (17)
CL Item
9-years (18)
CL Item
9.5-years (19)
CL Item
10-years (20)
CL Item
10.5-years (21)
CL Item
11-years (22)
CL Item
11.5-years (23)
CL Item
12-years (24)
CL Item
12.5-years (25)
CL Item
13-years (26)
Item
DRUSENOID PED FIELD 2 RT EYE (ALL PARTICIPANTS)
text
REDRUSF2
Code List
DRUSENOID PED FIELD 2 RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
NON-DRUSENOID PED FIELD 2 RT EYE (ALL PARTICIPANTS)
text
RENDRUF2
Code List
NON-DRUSENOID PED FIELD 2 RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
SSR/HEMORRHAGIC RD FIELD 2 RT EYE (ALL PARTICIPANTS)
text
RESSRF2
Code List
SSR/HEMORRHAGIC RD FIELD 2 RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
HARD EXUDATE FIELD 2 RT EYE (ALL PARTICIPANTS)
text
REHDEXF2
Code List
HARD EXUDATE FIELD 2 RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
SUBRETINAL/SUBRPE HEMORRHAGE FIELD 2 RT EYE (ALL PARTICIPANTS)
text
RESUBHF2
Code List
SUBRETINAL/SUBRPE HEMORRHAGE FIELD 2 RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
SUBRETINAL FIBROSIS FIELD 2 RT EYE (ALL PARTICIPANTS)
text
RESUBFF2
Code List
SUBRETINAL FIBROSIS FIELD 2 RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
PC/AMD FIELD 2 RT EYE (ALL PARTICIPANTS)
text
REPHCOF2
Code List
PC/AMD FIELD 2 RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
GEOGRAPHIC ATROPHY CENTER POINT RT EYE (ALL PARTICIPANTS)
text
REGEOACT
Code List
GEOGRAPHIC ATROPHY CENTER POINT RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, <Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Cannot Grade (8)
Item
GEOGRAPHIC ATROPHY AREA C/SUB RT EYE (ALL PARTICIPANTS)
text
REGEOACS
Code List
GEOGRAPHIC ATROPHY AREA C/SUB RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Cannot Grade (8)
Item
GEOGRAPHIC ATROPHY W/I GRID RT EYE (ALL PARTICIPANTS)
text
REGEOAWI
Code List
GEOGRAPHIC ATROPHY W/I GRID RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Definite, more than or equal to 0.5 DA in area (diameter, 0.707 DD), less than 1 DA in area (diameter, 1.000 DD) (5)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.000 DD), less than 2 DA in area (diameter, 1.414 DD) (6)
CL Item
Definite, more than or equal to 2.0 DA in area (diameter, 1.414 DD) (7)
CL Item
Cannot Grade (8)
Item
RPE DEPIGMENTATION AREA C/SUB+INNERS RT EYE (ALL PARTICIPANTS)
text
RERPEDCI
Code List
RPE DEPIGMENTATION AREA C/SUB+INNERS RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Definite, more than or equal to 0.5 DA in area (diameter, 0.707 DD), less than 1 DA in area (diameter, 1.000 DD) (5)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.000 DD), less than 2 DA in area (diameter, 1.414 DD) (6)
CL Item
Definite, more than or equal to 2.0 DA in area (diameter, 1.414 DD) (7)
CL Item
Cannot Grade (8)
Item
RPE DEPIGMENTATION AREA W/I GRID RT EYE (ALL PARTICIPANTS)
text
RERPEDWI
Code List
RPE DEPIGMENTATION AREA W/I GRID RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Definite, more than or equal to 0.5 DA in area (diameter, 0.707 DD), less than 1 DA in area (diameter, 1.000 DD) (5)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.000 DD), less than 2 DA in area (diameter, 1.414 DD) (6)
CL Item
Definite, more than or equal to 2.0 DA in area (diameter, 1.414 DD) (7)
CL Item
Cannot Grade (8)
Item
INCREASED PIGMENT AREA C/SUB+INNERS RT EYE (ALL PARTICIPANTS)
text
REINCPCI
Code List
INCREASED PIGMENT AREA C/SUB+INNERS RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle C0 (diameter, 0.042 DD; area, 0.0017 DA) (2)
CL Item
Definite, more than or equal to Circle C0 (diameter, 0.042 DD; area, 0.0017 DA), less than Circle C1 (diameter, 0.083 DD; area, 0.0069 DA) (3)
CL Item
Definite, more than or equal to Circle C1 (diameter, 0.083 DD; area, 0.0069 DA), less than Circle C2 (diameter, 0.167 DD; area, 0.028 DA) (4)
CL Item
Definite, more than or equal to Circle C2 (diameter, 0.167 DD; area, 0.028 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (5)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (6)
CL Item
Other (7)
CL Item
Cannot Grade (8)
Item
INCREASED PIGMENT AREA W/I GRID RT EYE (ALL PARTICIPANTS)
text
REINCPWI
Code List
INCREASED PIGMENT AREA W/I GRID RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle C0 (diameter, 0.042 DD; area, 0.0017 DA) (2)
CL Item
Definite, more than or equal to Circle C0 (diameter, 0.042 DD; area, 0.0017 DA), less than Circle C1 (diameter, 0.083 DD; area, 0.0069 DA) (3)
CL Item
Definite, more than or equal to Circle C1 (diameter, 0.083 DD; area, 0.0069 DA), less than Circle C2 (diameter, 0.167 DD; area, 0.028 DA) (4)
CL Item
Definite, more than or equal to Circle C2 (diameter, 0.167 DD; area, 0.028 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (5)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (6)
CL Item
Other (7)
CL Item
Cannot Grade (8)
Item
MAXIMUM DRUSEN SIZE W/I GRID RT EYE (ALL PARTICIPANTS)
text
REDRSZWI
Code List
MAXIMUM DRUSEN SIZE W/I GRID RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle C0 (63 microns) (2)
CL Item
Definite, more than or equal to Circle C0 (63 microns), less than Circle C1 (125 microns) (3)
CL Item
Definite, more than or equal to Circle C1 (125 microns), less than Circle C2 (250 microns) (4)
CL Item
Definite, more than or equal to Circle C2 (250 microns) (5)
CL Item
Cannot grade (8)
Item
SOFT DRUSEN RT EYE (ALL PARTICIPANTS)
text
REDRSOFT
Code List
SOFT DRUSEN RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Soft distinct (1)
CL Item
Soft indistinct (2)
CL Item
Cannot grade (8)
Item
DRUSEN AREA W/I GRID (ALL PARTICIPANTS)
text
REDRARWI
Code List
DRUSEN AREA W/I GRID (ALL PARTICIPANTS)
CL Item
None/Questionable/less than Circle C0 (diameter, 0.042 DD; area, 0.0017 DA) (0)
CL Item
Definite, more than or equal to Circle C0 (diameter, 0.042 DD; area, 0.0017 DA), less than Circle C1 (diameter, 0.083 DD;area, 0.0069 DA) (1)
CL Item
Definite, more than or equal to Circle C1 (diameter, 0.083 DD;area, 0.0069 DA), less than Circle C2 (diameter, 0.167 DD;area, 0.028 DA) (2)
CL Item
Definite, more than or equal to Circle C2 (diameter, 0.167 DD;area, 0.028 DA), less than Circle I2 (diameter, 0.241 DD;area, 0.058 DA) (3)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD;area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (4)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (5)
CL Item
Definite, more than or equal to 0.5 DA in area (diameter, 0.707 DD), less than 1 DA in area (diameter, 1.0 DD) (6)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.0 DD) (7)
CL Item
Cannot Grade (8)
CL Item
End Stage (9)
Item
RETICULAR DRUSEN RT EYE (ALL PARTICIPANTS)
text
REDRRETI
Code List
RETICULAR DRUSEN RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Outside grid (2)
CL Item
W/I grid +/- outside grid (3)
CL Item
Cannot grade (8)
Item
CALCIFIED DRUSEN W/I OR OUTSIDE GRID RT EYE (ALL PARTICIPANTS)
text
REDRCALC
Code List
CALCIFIED DRUSEN W/I OR OUTSIDE GRID RT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
DRUSEN CATEGORY RT EYE (ALL PARTICIPANTS)
text
REELICAT
Code List
DRUSEN CATEGORY RT EYE (ALL PARTICIPANTS)
CL Item
Category 1 (1)
CL Item
Category 2 (2)
CL Item
Category 3 (3)
CL Item
Category 4 (4)
CL Item
Disqualifying lesion (visno=00 only) (5)
CL Item
Cannot grade (8)
Item
DRUSENOID PED FIELD 2 LT EYE (ALL PARTICIPANTS)
text
LEDRUSF2
Code List
DRUSENOID PED FIELD 2 LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
NON-DRUSENOID PED FIELD 2 LT EYE (ALL PARTICIPANTS)
text
LENDRUF2
Code List
NON-DRUSENOID PED FIELD 2 LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
SSR/HEMORRHAGIC RD FIELD 2 LT EYE (ALL PARTICIPANTS)
text
LESSRF2
Code List
SSR/HEMORRHAGIC RD FIELD 2 LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
HARD EXUDATE FIELD 2 LT EYE (ALL PARTICIPANTS)
text
LEHDEXF2
Code List
HARD EXUDATE FIELD 2 LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
SUBRETINAL/SUBRPE HEMORRHAGE FIELD 2 LT EYE (ALL PARTICIPANTS)
text
LESUBHF2
Code List
SUBRETINAL/SUBRPE HEMORRHAGE FIELD 2 LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
SUBRETINAL FIBROSIS FIELD 2 LT EYE (ALL PARTICIPANTS)
text
LESUBFF2
Code List
SUBRETINAL FIBROSIS FIELD 2 LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
PC/AMD FIELD 2 LT EYE (ALL PARTICIPANTS)
text
LEPHCOF2
Code List
PC/AMD FIELD 2 LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
GEOGRAPHIC ATROPHY CENTER POINT LT EYE (ALL PARTICIPANTS)
text
LEGEOACT
Code List
GEOGRAPHIC ATROPHY CENTER POINT LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, <Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Cannot Grade (8)
Item
GEOGRAPHIC ATROPHY AREA C/SUB LT EYE (ALL PARTICIPANTS)
text
LEGEOACS
Code List
GEOGRAPHIC ATROPHY AREA C/SUB LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Cannot Grade (8)
Item
GEOGRAPHIC ATROPHY W/I GRID LT EYE (ALL PARTICIPANTS)
text
LEGEOAWI
Code List
GEOGRAPHIC ATROPHY W/I GRID LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Definite, more than or equal to 0.5 DA in area (diameter, 0.707 DD), less than 1 DA in area (diameter, 1.000 DD) (5)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.000 DD), less than 2 DA in area (diameter, 1.414 DD) (6)
CL Item
Definite, more than or equal to 2.0 DA in area (diameter, 1.414 DD) (7)
CL Item
Cannot Grade (8)
Item
RPE DEPIGMENTATION AREA C/SUB+INNERS LT EYE (ALL PARTICIPANTS)
text
LERPEDCI
Code List
RPE DEPIGMENTATION AREA C/SUB+INNERS LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Definite, more than or equal to 0.5 DA in area (diameter, 0.707 DD), less than 1 DA in area (diameter, 1.000 DD) (5)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.000 DD), less than 2 DA in area (diameter, 1.414 DD) (6)
CL Item
Definite, more than or equal to 2.0 DA in area (diameter, 1.414 DD) (7)
CL Item
Cannot Grade (8)
Item
RPE DEPIGMENTATION AREA W/I GRID LT EYE (ALL PARTICIPANTS)
text
LERPEDWI
Code List
RPE DEPIGMENTATION AREA W/I GRID LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (2)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (3)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (4)
CL Item
Definite, more than or equal to 0.5 DA in area (diameter, 0.707 DD), less than 1 DA in area (diameter, 1.000 DD) (5)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.000 DD), less than 2 DA in area (diameter, 1.414 DD) (6)
CL Item
Definite, more than or equal to 2.0 DA in area (diameter, 1.414 DD) (7)
CL Item
Cannot Grade (8)
Item
INCREASED PIGMENT AREA C/SUB+INNERS LT EYE (ALL PARTICIPANTS)
text
LEINCPCI
Code List
INCREASED PIGMENT AREA C/SUB+INNERS LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle C0 (diameter, 0.042 DD; area, 0.0017 DA) (2)
CL Item
Definite, more than or equal to Circle C0 (diameter, 0.042 DD; area, 0.0017 DA), less than Circle C1 (diameter, 0.083 DD; area, 0.0069 DA) (3)
CL Item
Definite, more than or equal to Circle C1 (diameter, 0.083 DD; area, 0.0069 DA), less than Circle C2 (diameter, 0.167 DD; area, 0.028 DA) (4)
CL Item
Definite, more than or equal to Circle C2 (diameter, 0.167 DD; area, 0.028 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (5)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (6)
CL Item
Other (7)
CL Item
Cannot Grade (8)
Item
INCREASED PIGMENT AREA W/I GRID LT EYE (ALL PARTICIPANTS)
text
LEINCPWI
Code List
INCREASED PIGMENT AREA W/I GRID LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle C0 (diameter, 0.042 DD; area, 0.0017 DA) (2)
CL Item
Definite, more than or equal to Circle C0 (diameter, 0.042 DD; area, 0.0017 DA), less than Circle C1 (diameter, 0.083 DD; area, 0.0069 DA) (3)
CL Item
Definite, more than or equal to Circle C1 (diameter, 0.083 DD; area, 0.0069 DA), less than Circle C2 (diameter, 0.167 DD; area, 0.028 DA) (4)
CL Item
Definite, more than or equal to Circle C2 (diameter, 0.167 DD; area, 0.028 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (5)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (6)
CL Item
Other (7)
CL Item
Cannot Grade (8)
Item
MAXIMUM DRUSEN SIZE W/I GRID LT EYE (ALL PARTICIPANTS)
text
LEDRSZWI
Code List
MAXIMUM DRUSEN SIZE W/I GRID LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Definite, less than Circle C0 (63 microns) (2)
CL Item
Definite, more than or equal to Circle C0 (63 microns), less than Circle C1 (125 microns) (3)
CL Item
Definite, more than or equal to Circle C1 (125 microns), less than Circle C2 (250 microns) (4)
CL Item
Definite, more than or equal to Circle C2 (250 microns) (5)
CL Item
Cannot grade (8)
Item
SOFT DRUSEN LT EYE (ALL PARTICIPANTS)
text
LEDRSOFT
Code List
SOFT DRUSEN LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Soft distinct (1)
CL Item
Soft indistinct (2)
CL Item
Cannot grade (8)
Item
DRUSEN AREA W/I GRID LT EYE (ALL PARTICIPANTS)
text
LEDRARWI
Code List
DRUSEN AREA W/I GRID LT EYE (ALL PARTICIPANTS)
CL Item
None/Questionable/less than Circle C0 (diameter, 0.042 DD; area, 0.0017 DA) (0)
CL Item
Definite, more than or equal to Circle C0 (diameter, 0.042 DD; area, 0.0017 DA), less than Circle C1 (diameter, 0.083 DD; area, 0.0069 DA) (1)
CL Item
Definite, more than or equal to Circle C1 (diameter, 0.083 DD; area, 0.0069 DA), less than Circle C2 (diameter, 0.167 DD; area, 0.028 DA) (2)
CL Item
Definite, more than or equal to Circle C2 (diameter, 0.167 DD; area, 0.028 DA), less than Circle I2 (diameter, 0.241 DD; area, 0.058 DA) (3)
CL Item
Definite, more than or equal to Circle I2 (diameter, 0.241 DD; area, 0.058 DA), less than Circle O2 (diameter, 0.439 DD; area, 0.19 DA) (4)
CL Item
Definite, more than or equal to Circle O2 (diameter, 0.439 DD; area, 0.19 DA), less than 0.5 DA in area (diameter, 0.707 DD) (5)
CL Item
Definite, larger than or equal to 0.5 DA in area (diameter, 0.707 DD), less 1 DA in area (diameter, 1.0 DD) (6)
CL Item
Definite, more than or equal to 1.0 DA in area (diameter, 1.0 DD) (7)
CL Item
Cannot Grade (8)
CL Item
End Stage (9)
Item
RETICULAR DRUSEN LT EYE (ALL PARTICIPANTS)
text
LEDRRETI
Code List
RETICULAR DRUSEN LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Outside grid (2)
CL Item
W/I grid +/- outside grid (3)
CL Item
Cannot grade (8)
Item
CALCIFIED DRUSEN W/I OR OUTSIDE GRID LT EYE (ALL PARTICIPANTS)
text
LEDRCALC
Code List
CALCIFIED DRUSEN W/I OR OUTSIDE GRID LT EYE (ALL PARTICIPANTS)
CL Item
None (0)
CL Item
Questionable (1)
CL Item
Yes (2)
CL Item
Cannot grade (8)
Item
DRUSEN CATEGORY LT EYE (ALL PARTICIPANTS)
text
LEELICAT
Code List
DRUSEN CATEGORY LT EYE (ALL PARTICIPANTS)
CL Item
Category 1 (1)
CL Item
Category 2 (2)
CL Item
Category 3 (3)
CL Item
Category 4 (4)
CL Item
Disqualifying lesion (visno=00 only) (5)
CL Item
Cannot grade (8)
Item
PARTICIPANT DRUSEN CATEGORY (WORSE EYE; ALL PARTICIPANTS)
text
DRUCAT
Code List
PARTICIPANT DRUSEN CATEGORY (WORSE EYE; ALL PARTICIPANTS)
CL Item
Category 1 (both eyes) (1)
CL Item
Category 2 (2)
CL Item
Category 3 (3)
CL Item
Category 4 (one eye) (4)
CL Item
Category 4 (both eyes) (5)
CL Item
Cannot grade (8)
CL Item
Category 3a (3a)
CL Item
Category 3b (3b)
Item
AMD SEVERITY SCALE SCORE LT EYE (ALL PARTICIPANTS)
text
AMDSEVLE
Code List
AMD SEVERITY SCALE SCORE LT EYE (ALL PARTICIPANTS)
CL Item
Scale Step 1 (1)
CL Item
Scale Step 2 (2)
CL Item
Scale Step 3 (3)
CL Item
Scale Step 4 (4)
CL Item
Scale Step 5 (5)
CL Item
Scale Step 6 (6)
CL Item
Scale Step 7 (7)
CL Item
Scale Step 8 (8)
CL Item
Scale Step 9 (9)
CL Item
Central Geographic Atrophy (10)
CL Item
Neovascular AMD (11)
CL Item
Neovascular AMD and Central Geographic Atrophy (12)
Item
AMD SEVERITY SCALE SCORE RT EYE (ALL PARTICIPANTS)
text
AMDSEVRE
Code List
AMD SEVERITY SCALE SCORE RT EYE (ALL PARTICIPANTS)
CL Item
Scale Step 1 (1)
CL Item
Scale Step 2 (2)
CL Item
Scale Step 3 (3)
CL Item
Scale Step 4 (4)
CL Item
Scale Step 5 (5)
CL Item
Scale Step 6 (6)
CL Item
Scale Step 7 (7)
CL Item
Scale Step 8 (8)
CL Item
Scale Step 9 (9)
CL Item
Central Geographic Atrophy (10)
CL Item
Neovascular AMD (11)
CL Item
Neovascular AMD and Central Geographic Atrophy (12)
SCALE
Item
AMD SIMPLE SCALE SCORE (PERSON; ALL PARTICIPANTS)
text
Item
LAST PHOTO IN CLINICAL TRIAL (ALL PARTICIPANTS)
text
LASTCLINF
Code List
LAST PHOTO IN CLINICAL TRIAL (ALL PARTICIPANTS)
CL Item
Yes (Y)
REPHTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF FUNDUS PHOTO RT EYE (ALL PARTICIPANTS)
float
LEPHTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF FUNDUS PHOTO LT EYE (ALL PARTICIPANTS)
float
Back to the top of the page